Related Experiment Video
Updated: May 11, 2026

08:04
Pancreatic Tissue Dissection to Isolate Viable Single Cells
Published on: May 26, 2023
Integrative single-cell and spatial multi-Omics analyses identify NETs-driven colon cancer subtypes with distinct
Xiao-Long Tang1, Yi He1, Wen-Yu Luan2
1The Second Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong City, Sichuan Province, 637000, China.
Journal of Translational Medicine
|May 9, 2026
Summary
Neutrophil extracellular traps (NETs) influence colon cancer progression and treatment resistance. A four-gene signature shows potential for risk stratification, highlighting NETs
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Colon cancer is a leading cause of cancer deaths with high recurrence rates.
- The tumor microenvironment (TME) significantly impacts tumor progression and treatment resistance.
- Neutrophil extracellular traps (NETs) are implicated in tumor invasion, metastasis, and immune evasion, but their role in colon cancer is unclear.
Purpose of the Study:
- To investigate the role of NETs-associated genes in colon cancer.
- To identify molecular subtypes and develop a prognostic model for colon cancer based on NETs-related genes.
Main Methods:
- Transcriptomic analyses using TCGA and GEO datasets.
- Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics.
- Multivariate Cox and LASSO regression for prognostic model construction and validation.
- Colocalization analysis of genetic data.
Main Results:
- Two distinct NETs-related molecular subtypes of colon cancer were identified with differences in immune composition and metabolism.
- NETs-high colon cancer cells exhibit metabolic reprogramming linked to immune escape and therapeutic resistance.
- A four-gene prognostic signature (ARRDC1, TUBB2A, DUSP5, SLC2A3) demonstrated moderate prognostic discrimination.
- Increased TUBB2A expression correlated with adverse clinical outcomes.
Conclusions:
- NETs-associated genes are critical in colon cancer progression, immune modulation, and metabolic reprogramming.
- The identified four-gene signature is a potential candidate biomarker for colon cancer risk stratification, requiring further validation.
